Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Solventum (SOLV) Research & Development (2023 - 2025)

Solventum (SOLV) has disclosed Research & Development for 2 consecutive years, with $199.0 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Research & Development rose 4.74% year-over-year to $199.0 million, compared with a TTM value of $775.0 million through Dec 2024, up 2.24%, and an annual FY2024 reading of $775.0 million, up 2.24% over the prior year.
  • Research & Development was $199.0 million for Q4 2024 at Solventum, up from $189.0 million in the prior quarter.
  • Across five years, Research & Development topped out at $199.0 million in Q4 2024 and bottomed at $180.0 million in Q3 2023.